上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
N-Bis(2-hydroxypropyl)nitrosamine (Synonyms: DHPN; Di(2-hydroxypropyl)nitrosamine; Diisopropanolnitrosamine) 纯度: ≥98.0%
N-Bis(2-hydroxypropyl)nitrosamine 是一种具有致癌作用的试剂。
N-Bis(2-hydroxypropyl)nitrosamine Chemical Structure
CAS No. : 53609-64-6
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
Free Sample (0.1-0.5 mg) | Apply now | ||
10 mM * 1 mL in DMSO | ¥660 | In-stock | |
10 mg | ¥600 | In-stock | |
25 mg | ¥1200 | In-stock | |
50 mg | ¥1900 | In-stock | |
100 mg | ¥2900 | In-stock | |
200 mg | ¥4900 | In-stock | |
500 mg | 询价 | ||
1 g | 询价 |
* Please select Quantity before adding items.
N-Bis(2-hydroxypropyl)nitrosamine 相关产品
•相关化合物库:
- Bioactive Compound Library Plus
- Anti-Cancer Compound Library
生物活性 |
N-Bis(2-hydroxypropyl)nitrosamine is an agent with carcinogenic activity. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
N-Bis(2-hydroxypropyl)nitrosamine is an agent with carcinogenic activity[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
体内研究 (In Vivo) |
N-Bis(2-hydroxypropyl)nitrosamine causes the tumors to develop in the lung, liver, and thyroid of rats at a dose of 100 ppm, in the lung, liver thyroid, esophagus, kidney, and urinary bladder of rats at a dose of 500 ppm, and in the lung, liver thyroid, esophagus, kidney, and urinary bladder of rats at both doses[1]. Bisphenol A (BPA) enhances the susceptibility to thyroid carcinoma stimulated by N-Bis(2-hydroxypropyl)nitrosamine (DHPN; 2800 mg/kg) in rats[2]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
162.19 |
||||||||||||||||
Formula |
C6H14N2O3 |
||||||||||||||||
CAS 号 |
53609-64-6 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : ≥ 125 mg/mL (770.70 mM) * “≥” means soluble, but saturation unknown. 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务